Roche Advances Novel Antibiotic Targeting Superbug into Phase 3 Trials
Swiss pharmaceutical company Roche has announced plans to advance its experimental antibiotic, zosurabalpin, into Phase 3 clinical trials. Developed in
Read moreSwiss pharmaceutical company Roche has announced plans to advance its experimental antibiotic, zosurabalpin, into Phase 3 clinical trials. Developed in
Read moreThe worldwide product rights for the Astelas’ top systemic antifungal agent Mycamine® (micafungin sodium, known as Funguard® in Japan) have
Read morePfizer announced on Wednesday, the acquisition of Amplyx Pharmaceuticals, Inc., a privately-owned company focused on the engineering of treatments for
Read moreGrange Castle Biotechnology Plant is one of the biggest integrated biotechnology plants in the world. Owned by the world-leading biotech
Read moreThe GlaxoSmithKline Irvine, North Ayrshire, antibiotic plant is located in i3, Irvine’s life sciences enterprise area. GSK’s Irvine plant produces
Read more